Rocket One Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
Rocket One Inc. (RKTO) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $9.97 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-14
- Rocket One Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $111.05K.
- Rocket One Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $166.57K.
- Rocket One Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-06-30 was $55.52K.
- Rocket One Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-03-31 was $4.35K.
- Rocket One Inc. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $333.15K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.97K 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | $111.05K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $277.63K derived: sum of 2 quarters · filed 2026-03-27 | $333.15K derived: sum of 3 quarters · filed 2026-08-14 | $333.15K 10-K · filed 2026-03-27 |
| 2025-09-30 | $166.57K 10-Q · filed 2025-11-12 | $222.10K derived: sum of 2 quarters · filed 2026-08-14 | $222.10K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $55.52K 10-Q · filed 2026-08-14 | $55.52K 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $4.35K 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |